TAGS: A Phase Iii, Randomised, Double-Blind Study of Trifluridine/Tipiracil (Tas-102) Versus Placebo in Patients with Refractory Metastatic Gastric Cancer
AuthID
P-00Q-93N
P-00Q-93N
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service